Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1928 2
1929 2
1930 1
1935 1
1945 4
1946 5
1947 2
1948 1
1949 2
1950 4
1951 5
1952 9
1953 5
1954 4
1955 2
1956 1
1958 3
1959 3
1960 5
1961 4
1962 7
1963 8
1964 7
1965 4
1966 7
1967 1
1968 8
1969 11
1970 7
1971 9
1972 13
1973 25
1974 25
1975 22
1976 19
1977 25
1978 26
1979 21
1980 26
1981 18
1982 19
1983 34
1984 40
1985 44
1986 54
1987 52
1988 52
1989 41
1990 58
1991 63
1992 59
1993 74
1994 53
1995 57
1996 47
1997 38
1998 65
1999 73
2000 71
2001 75
2002 65
2003 72
2004 79
2005 80
2006 88
2007 96
2008 92
2009 96
2010 102
2011 109
2012 122
2013 138
2014 166
2015 210
2016 206
2017 194
2018 208
2019 191
2020 226
2021 258
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

3,957 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Jeroue
Page 1
Did you mean lacey jerome (7 results)?
Reply.
Holz FG, Figueroa MS, Bandello F, Yang Y, Ohji M, Dai H, Wykrota H, Sharma S, Dunger-Baldauf C, Lacey S, Macfadden W, Mitchell P; all the LUMINOUS study investigators. Holz FG, et al. Retina. 2020 Sep;40(9):e51-e53. doi: 10.1097/IAE.0000000000002909. Retina. 2020. PMID: 32842092 No abstract available.
Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia.
Mueller KT, Maude SL, Porter DL, Frey N, Wood P, Han X, Waldron E, Chakraborty A, Awasthi R, Levine BL, Melenhorst JJ, Grupp SA, June CH, Lacey SF. Mueller KT, et al. Blood. 2017 Nov 23;130(21):2317-2325. doi: 10.1182/blood-2017-06-786129. Epub 2017 Sep 21. Blood. 2017. PMID: 28935694 Free PMC article.
Tisagenlecleucel (CTL019) is an investigational immunotherapy that involves reprogramming a patient's own T cells with a transgene encoding a chimeric antigen receptor to identify and eliminate CD19-expressing cells. ...
Tisagenlecleucel (CTL019) is an investigational immunotherapy that involves reprogramming a patient's own T cells with a transgene en …
'You Don't Have Any Business Being This Good': An Oral History Interview with Bernardine Lacey.
Lewenson SB, Graham-Perel A. Lewenson SB, et al. Am J Nurs. 2020 Aug;120(8):40-47. doi: 10.1097/01.NAJ.0000694564.56696.ad. Am J Nurs. 2020. PMID: 32732477
Racism left an indelible mark on Bernardine Lacey and her professional growth as a nurse, including roles as an educator, political advocate, researcher, clinician, and leader. This article uses oral history methods to detail, in Lacey's own words, experience …
Racism left an indelible mark on Bernardine Lacey and her professional growth as a nurse, including roles as an educator, political a …
Authors' reply.
Lacey R, McMunn A, Webb E. Lacey R, et al. Maturitas. 2018 Jun;112:95. doi: 10.1016/j.maturitas.2018.03.002. Epub 2018 Mar 13. Maturitas. 2018. PMID: 29551469 No abstract available.
Charles David Lacey.
Lacey G. Lacey G. BMJ. 2017 Apr 21;357:j1929. doi: 10.1136/bmj.j1929. BMJ. 2017. PMID: 28432044 No abstract available.
3,957 results